Clinical Heterogeneity in Two Siblings Harbouring a Heterozygous PRPH2 Pathogenic Variant
Klinische Monatsblätter für Augenheilkunde · 01.04.2023 · 240 (04) · 536-543
DOI: 10.1055/a-2034-6250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2023. Verfasst von Ayse Sanlialp und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. Hauptthemen laut MEDLINE: Cone-Rod Dystrophies, Retinal Dystrophies, Retinitis Pigmentosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Purpose
The aim of the study was to describe the clinical and genetic correlation of a c.469 G>A p.(Asp157Asn) heterozygous pathogenic variant in PRPH2 in two siblings of Italian origin. Patients and Methods Both patients underwent ophthalmic examination, electrophysiological testing, autofluorescence imaging, and optical coherence tomography (OCT). Screening for pathogenic variants of the obtained DNA from the family members was carried out.
Results
The 52-year-old (♀, index patient) and 50-year-old (♂) siblings had BCVA (OD and OS) of 20/20 and 20/16 (♀) and 20/25 and 20/40 (♂), respectively, and suffered increased sensitivity to glare. Yellow irregular macular deposits, numerous small irregular hypo- and hyperreflective spots at the posterior pole, a patchy loss of photoreceptors, and retinal pigment epithelium (RPE) in the perifoveal region were seen. Electrophysiology showed dysfunction of rods and cones, with more affected cone dysfunction in the index patient, contrary to the generalised rod dysfunction in the brother of the index patient. The clinical, electrophysiological, and multimodal imaging findings of both siblings pointed towards Stargardt retinopathy with heterogenic presentation. The DNA analysis identified an autosomal dominant c.469 G>A p.(Asp157Asn) heterozygous pathogenic variant in PRPH2 associated with autosomal dominant cone-rod dystrophy and rod-cone dystrophy. PRPH2 codes for peripherin-2, a membrane protein that consists of 346 amino acids.
Conclusions
Our findings confirm a heterogeneity in clinical presentation associated with pathogenic variants in PRPH2. It may follow either an autosomal dominant or an autosomal recessive mode of inheritance and show a very heterogeneous clinical manifestation of retinal degeneration, e.g., autosomal dominant retinitis pigmentosa (♂ sibling; II-3) and autosomal dominant cone-rod dystrophy (index ♀ sibling; II-2), autosomal dominant macular dystrophy, and also autosomal recessive retinitis pigmentosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
- Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Human Genetics, Department of Pediatrics, Inselspital, Bern University Hospital, Bern, Switzerland.
- Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.
Zitieren
APA
Sanlialp, A., Escher, P., Schaller, A., & Todorova, M. (2023). Clinical Heterogeneity in Two Siblings Harbouring a Heterozygous PRPH2 Pathogenic Variant. Klinische Monatsblätter für Augenheilkunde, 240(04), 536-543. https://doi.org/10.1055/a-2034-6250
Vancouver
Sanlialp A, Escher P, Schaller A, Todorova M. Clinical Heterogeneity in Two Siblings Harbouring a Heterozygous PRPH2 Pathogenic Variant. Klinische Monatsblätter für Augenheilkunde. 2023;240(04):536-543. doi:10.1055/a-2034-6250
BibTeX
@article{Sanlialp2023,
author = {Sanlialp, Ayse and Escher, Pascal and Schaller, André and Todorova, Margarita},
title = {Clinical Heterogeneity in Two Siblings Harbouring a Heterozygous PRPH2 Pathogenic Variant},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2023},
volume = {240},
number = {04},
pages = {536--543},
doi = {10.1055/a-2034-6250}
}
EUVIMED